ESSA Pharma Inc. Quarterly Earnings Per Share, Diluted in USD/shares from Q1 2021 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
ESSA Pharma Inc. quarterly/annual Earnings Per Share, Diluted history and growth rate from Q1 2021 to Q2 2024.
- ESSA Pharma Inc. Earnings Per Share, Diluted for the quarter ending June 30, 2024 was -0.16 USD/shares, a 5.88% increase year-over-year.
- ESSA Pharma Inc. Earnings Per Share, Diluted for the twelve months ending June 30, 2024 was -0.62 USD/shares, unchanged year-over-year.
- ESSA Pharma Inc. annual Earnings Per Share, Diluted for 2023 was -0.6 USD/shares, a 25% increase from 2022.
- ESSA Pharma Inc. annual Earnings Per Share, Diluted for 2022 was -0.8 USD/shares, a 16.7% increase from 2021.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Growth (%)